Endovascular management of porto-mesenteric venous thrombosis developing after trans-arterial occlusion of a superior mesenteric arteriovenous fistula

2013 ◽  
Vol 32 (5) ◽  
pp. 341-345 ◽  
Author(s):  
Deepak Garg ◽  
Jorge Enrique Lopera ◽  
Anthony D. Goei
Keyword(s):  
Venous Thrombosis ◽  
Arteriovenous Fistula ◽  
Arterial Occlusion ◽  
Mesenteric Venous Thrombosis ◽  
Endovascular Management

scholarly journals Superior Mesenteric Venous Thrombosis Outcomes and Endovascular Management

2020 ◽  
Vol 72 (1) ◽  
pp. e160
Author(s):  
Khaled I. Alnahhal ◽  
Houssam Farres ◽  
Samuel Nussbaum ◽  
Young Erben ◽  
Albert Hakaim ◽  
...  
Keyword(s):  
Venous Thrombosis ◽  
Mesenteric Venous Thrombosis ◽  
Endovascular Management

scholarly journals Superior mesenteric venous thrombosis: Endovascular management and outcomes

2022 ◽  
Vol 10 (1) ◽  
pp. 217-226
Author(s):  
Khaled Alnahhal ◽  
Beau B Toskich ◽  
Samuel Nussbaum ◽  
Zhuo Li ◽  
Young Erben ◽  
...  
Keyword(s):  
Venous Thrombosis ◽  
Mesenteric Venous Thrombosis ◽  
Endovascular Management

Mesenteric Venous Thrombosis

2015 ◽  
Author(s):  
Matthew J Eagleton ◽  
Michael O’Neil
Keyword(s):  
Risk Factors ◽  
Venous Thrombosis ◽  
Arterial Occlusion ◽  
Mesenteric Venous Thrombosis ◽  
Radiologic Findings ◽  
Difficult Condition ◽  
Portal Veins ◽  
Low Incidence ◽  
Spectrum Of Patients ◽  
Transhepatic Access

Mesenteric venous thrombosis (MVT) is a rare but potentially lethal form of mesenteric ischemia. MVT is a difficult condition to diagnose within the spectrum of patients presenting with acute or subacute abdominal pain. The nonspecific symptoms, low incidence, and lack of awareness among clinicians are some of the causes for this. The etiology of this disease results from a heterogeneous group of underlying pathologic disorders and risk factors that make this disease challenging to diagnose and treat. This review discusses the etiology, pathophysiology, clinical presentation, diagnosis, treatment, and outcomes of MVT. Tables outline conditions associated with secondary MVT, distinctions between acute MVT and acute mesenteric arterial occlusion, radiologic findings associated with acute MVT, and risk factors for mortality associated with acute MVT. Figures show acute MVT, transmural and nontransmural bowel ischemia, transhepatic access and venography, venography of the superior mesenteric and portal veins, and bowel appearance at abdominal exploration of a patient with acute MVT. This review contains 6 figures, 4 tables, and 58 references.

scholarly journals Deep Cerebral Venous Thrombosis—A Clinicoradiological Study

2021 ◽  
Author(s):  
Sujana Gogineni ◽  
Dhananjay Gupta ◽  
R. Pradeep ◽  
Anish Mehta ◽  
Mahendra Javali ◽  
...  
Keyword(s):  
Venous Thrombosis ◽  
Care Center ◽  
Tertiary Care ◽  
Clinical Manifestations ◽  
Arterial Occlusion ◽  
Venous System ◽  
Common Risk Factor ◽  
Imaging Characteristics ◽  
Deep Cerebral Venous Thrombosis ◽  
High Index Of Suspicion

AbstractStroke is a common neurological emergency. Almost 80% of strokes are due to arterial occlusion. Venous thrombosis comprises less than 1–2% of all strokes. Involvement of the deep cerebral venous system is still rare and accounts for about 10.9% of all cerebral venous thromboses (CVT). CVT diagnosis is often delayed or missed, because of its variable clinical manifestations. We retrospectively (2015–18) and prospectively (2018–20) reviewed all the cases of CVT in a tertiary care center in south India. Out of a total of 52 CVT cases, 12 were due to the involvement of deep cerebral venous system. Their clinical presentation, imaging characteristics, and outcomes were assessed. The most frequent presentation was headache followed by seizures. Hyperhomocysteinemia was the most common risk factor noted. Imaging characteristics were variable, and a high index of suspicion was required for early diagnosis. All patients had favorable outcome in our study, and except one, all were treated conservatively.

A systematic review and meta-analysis on endovascular treatment as an attractive alternative for acute superior mesenteric venous thrombosis

Vascular ◽  
2021 ◽  
pp. 170853812199127
Author(s):  
Lixin Wang ◽  
Enci Wang ◽  
Fei Liu ◽  
Wei Zhang ◽  
Xiaolong Shu ◽  
...  
Keyword(s):  
Systematic Review ◽  
Treatment Group ◽  
Conservative Treatment ◽  
Venous Thrombosis ◽  
Endovascular Treatment ◽  
Meta Analysis ◽  
Statistical Significance ◽  
Published Data ◽  
Mesenteric Venous Thrombosis ◽  
Surgery Group

Objective This systematic review and meta-analysis evaluated the published data on the efficacy and safety of therapies for superior mesenteric venous thrombosis (SMVT), aiming to provide a reference and set of recommendations for clinical treatment. Methods Relevant databases were searched for studies published from 2000 to June 2020 on SMVT treated with conservative treatment, surgical treatment, or endovascular approach. Different treatment types were grouped for analysis and comparison, and odds ratios with corresponding 95% confidence intervals were calculated. The outcomes were pooled using meta-analytic methods and presented by forest plots. Results Eighteen articles, including eight on SMVT patients treated with endovascular therapies, were enrolled. The treatment effectiveness was compared between different groups according to the change of symptoms, the occurrence of complications, and mortality as well. The conservative treatment group had better efficacy compared to the surgery group (89.0% vs. 78.6%, P <0.05), and the one-year survival rate was also higher (94.4% vs. 80.0%, P >0.05), but without statistical significance. As for endovascular treatment, the effectiveness was significantly higher than the surgery group (94.8% vs. 75.2%, P <0.05), and the conservative treatment group as well (93.3% vs. 86.3%, P >0.05), which still requires further research for the lack of statistical significance. Conclusions Present findings indicate that anticoagulation, as conservative treatment should be the preferred clinical option in the clinic for SMVT, due to its better curative effect compared to other treatment options, including lower mortality, fewer complications, and better prognosis. Moreover, endovascular treatment is a feasible and promising approach that is worth in-depth research, for it is less invasive than surgery and has relatively better effectiveness, thus can provide an alternative option for SMVT treatment and may be considered as a reliable method in clinical.

TIPS for Noncirrhotic Adults with Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard of Care Therapy

Hepatology ◽  
2021 ◽  
Author(s):  
Gabriel M. Knight ◽  
Jeffrey Clark ◽  
Justin R. Boike ◽  
Haripriya Maddur ◽  
Daniel R. Ganger ◽  
...  
Keyword(s):  
Venous Thrombosis ◽  
Standard Of Care ◽  
Mesenteric Venous Thrombosis

Concurrent Factor V Leiden and Protein C Deficiency Presenting as Mesenteric Venous Thrombosis

2016 ◽  
Vol 82 (4) ◽  
pp. 96-98 ◽  
Author(s):  
Lev N. Korovin ◽  
Mustafa Raoof ◽  
John B. Kettelle ◽  
James H. McClenathan ◽  
Jitesh A. Patel
Keyword(s):  
Venous Thrombosis ◽  
Protein C ◽  
Factor V Leiden ◽  
Factor V ◽  
Mesenteric Venous Thrombosis ◽  
Protein C Deficiency
Sign in / Sign up

Export Citation Format

Share Document